
Tarsus Pharmaceuticals Inc
NASDAQ:TARS

Intrinsic Value
The intrinsic value of one
TARS
stock under the Base Case scenario is
60.64
USD.
Compared to the current market price of 51.74 USD,
Tarsus Pharmaceuticals Inc
is
Undervalued by 15%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Tarsus Pharmaceuticals Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Tarsus Pharmaceuticals Inc
Balance Sheet Decomposition
Tarsus Pharmaceuticals Inc
Current Assets | 356.7m |
Cash & Short-Term Investments | 291.4m |
Receivables | 48.1m |
Other Current Assets | 17.3m |
Non-Current Assets | 20.3m |
Long-Term Investments | 3m |
PP&E | 2.9m |
Intangibles | 8.3m |
Other Non-Current Assets | 6.1m |
Free Cash Flow Analysis
Tarsus Pharmaceuticals Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Tarsus Pharmaceuticals Inc
Revenue
|
183m
USD
|
Cost of Revenue
|
-12.8m
USD
|
Gross Profit
|
170.1m
USD
|
Operating Expenses
|
-290.7m
USD
|
Operating Income
|
-120.6m
USD
|
Other Expenses
|
5m
USD
|
Net Income
|
-115.6m
USD
|
TARS Profitability Score
Profitability Due Diligence
Tarsus Pharmaceuticals Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

Score
Tarsus Pharmaceuticals Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.
TARS Solvency Score
Solvency Due Diligence
Tarsus Pharmaceuticals Inc's solvency score is 70/100. The higher the solvency score, the more solvent the company is.

Score
Tarsus Pharmaceuticals Inc's solvency score is 70/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TARS Price Targets Summary
Tarsus Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
TARS
is 68.98 USD
with a low forecast of 45.45 USD and a high forecast of 89.25 USD.
Dividends
Current shareholder yield for TARS is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
TARS
stock under the Base Case scenario is
60.64
USD.
Compared to the current market price of 51.74 USD,
Tarsus Pharmaceuticals Inc
is
Undervalued by 15%.